APA (7th ed.) Citation

Mamlins, E., Scharbert, L., Cardinale, J., Krotov, M., Winter, E., Rathke, H., . . . Giesel, F. L. (2023). The theranostic optimization of PSMA-GCK01 does not compromise the imaging characteristics of [99mTc]Tc-PSMA-GCK01 compared to dedicated diagnostic [99mTc]Tc-EDDA/HYNIC-iPSMA in prostate cancer. Molecular imaging & biology. https://doi.org/10.1007/s11307-023-01881-y

Chicago Style (17th ed.) Citation

Mamlins, Eduards, et al. "The Theranostic Optimization of PSMA-GCK01 Does Not Compromise the Imaging Characteristics of [99mTc]Tc-PSMA-GCK01 Compared to Dedicated Diagnostic [99mTc]Tc-EDDA/HYNIC-iPSMA in Prostate Cancer." Molecular Imaging & Biology 2023. https://doi.org/10.1007/s11307-023-01881-y.

MLA (9th ed.) Citation

Mamlins, Eduards, et al. "The Theranostic Optimization of PSMA-GCK01 Does Not Compromise the Imaging Characteristics of [99mTc]Tc-PSMA-GCK01 Compared to Dedicated Diagnostic [99mTc]Tc-EDDA/HYNIC-iPSMA in Prostate Cancer." Molecular Imaging & Biology, 2023, https://doi.org/10.1007/s11307-023-01881-y.